STOCK TITAN

Biolargo - BLGO STOCK NEWS

Welcome to our dedicated page for Biolargo news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on Biolargo stock.

Biolargo, Inc. (BLGO) delivers innovative cleantech solutions for critical environmental challenges, from advanced water treatment to sustainable energy storage. This news hub provides investors and industry professionals with timely updates on the company’s progress in commercializing its technologies.

Discover official press releases, financial announcements, and operational milestones related to BLGO’s core initiatives: PFAS remediation systems, water treatment innovations, Cellinity energy storage technology, and strategic partnerships. The page serves as a neutral, factual resource for tracking the company’s execution of its environmental technology roadmap.

Key updates include regulatory developments, patent approvals, partnership agreements, and product commercialization efforts. All content is curated to meet investor needs for decision-ready information while adhering to financial disclosure standards.

Bookmark this page or check back regularly for verified updates directly from Biolargo and trusted financial news sources. For historical context, explore archived announcements demonstrating the company’s evolving cleantech portfolio.

Rhea-AI Summary

BioLargo, Inc. (OTCQB: BLGO) will host an investor webcast on May 19, 2022, at 1:00 PM PT to discuss Q1 financial results, recent milestones, and future projects. This public event allows for audience interaction during a Q&A session. Participants can access the webcast via a provided link and will have the opportunity to listen to a replay afterward. BioLargo focuses on cleantech solutions including environmental engineering and has developed numerous innovative technologies, holding numerous patents and grants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) reported a record revenue of $965,000 for Q1 2022, a 69% increase from the previous year. Its subsidiary, ONM Environmental, achieved its first profitable quarter with $598,000 in revenue and a $13,000 operating profit. The Engineering division generated $355,000, significantly improving from a $183,000 loss last year. BioLargo is developing innovative solutions for PFAS contamination and progressing partnerships in private-label products and water treatment, aiming for substantial future revenue growth and positive cash flow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) reported a quarterly revenue record of approximately $900,000 for Q1 2022, marking a 60% increase from Q1 2021. The company's subsidiaries, ONM Environmental and BioLargo Engineering, contributed $550,000 and $350,000 to this revenue, respectively. Additionally, BioLargo Engineering has been awarded a feasibility contract for a waste-to-energy conversion plant in South America, potentially worth over $500 million. This project could engage BioLargo for the next four years, supporting its growth strategy in sustainable technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) will host an investor webcast and conference call on April 4, 2022, at 1:30 pm PT to discuss year-end financial results and recent commercial milestones. The public can participate through a webcast or teleconference. The event aims to enhance investor relations by providing insights into the company’s performance and future plans. A replay will be available until April 18, 2022, for the teleconference, and until April 4, 2023, for the webcast. BioLargo specializes in innovative technologies for environmental challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) has filed its Annual Report on Form 10-K for 2021, showcasing significant financial and commercial advancements. The company reported a 4% revenue increase to $2.53 million, despite a 14% year-over-year revenue decline in Q4. Total debt decreased from $2.9 million to $681,000, while net loss fell by 29% to $6.9 million. Key developments include partnerships for PFAS treatment technology and a successful market introduction of new products. An investor webcast will be held on April 4, 2022, to discuss further details and future growth opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) announced progress on three key growth initiatives:

  • The Minimal Liquid Discharge Water Treatment System successfully passed factory acceptance testing, demonstrating over 98% contaminant removal.
  • The Aqueous Electrostatic Concentrator (AEC) for PFAS removal is advancing with ongoing studies and potential field trials.
  • Collaborations with Ikigai Marketing Works are showing promise in the rollout of a new pet odor control product, exceeding initial expectations.

The company emphasizes its commitment to innovation and sustainability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) announced that its Aqueous Electrostatic Concentrator (AEC) successfully eliminated multiple PFAS compounds from municipal water in Southern California. PFAS, harmful chemicals linked to serious health concerns and persistent in the environment, are facing increased regulatory scrutiny. The AEC technology has shown the ability to reduce PFAS levels below quantification limits, confirming its efficacy in providing safe drinking water. This advancement is crucial as BioLargo prepares for commercial trials and sales, positioning itself as a leader in PFAS removal solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) is advancing the commercialization of its innovative wastewater treatment technology, the minimal liquid discharge system, developed for Garratt-Callahan. The company will use a full-scale prototype to treat simulated and actual industrial wastewater, aimed at optimizing performance before sales to Garratt-Callahan customers begin. This technology is designed to reduce wastewater volume and disposal costs, while also enhancing environmental sustainability. BioLargo emphasizes its commitment to sustainable solutions and innovation in wastewater treatment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) has entered into a manufacturer's representative agreement with ICS Group, focusing on the sale of its innovative water treatment technologies. This partnership marks a significant step in expanding BioLargo's commercial network. ICS Group will promote BioLargo's proprietary solutions, including the Advanced Oxidation System and the Aqueous Electrostatic Concentrator, designed for wastewater treatment and PFAS contamination removal. The deal also includes BioLargo's PFAS Testing Program and CupriDyne Clean odor control product.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

BioLargo, Inc. (OTCQB:BLGO) has received a 'go decision' from its partner Ikigai Holdings to expand television advertising for its new pet odor control product, 'POOPH'. The decision follows successful test marketing results, indicating strong potential for the product's commercial success. Ikigai CEO Jane Pak highlighted positive early feedback and plans for an extensive marketing campaign post-Christmas. BioLargo CEO Dennis P. Calvert mentioned the partnership could generate significant revenue, with Ikigai managing product rollout and distribution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.52%
Tags
partnership
Biolargo

OTC:BLGO

BLGO Rankings

BLGO Stock Data

88.55M
253.84M
14.01%
0.04%
Chemicals
Basic Materials
Link
United States
Westminster